Theravance Biopharma Inc
NASDAQ:TBPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cosco Capital Inc
XPHS:COSCO
|
PH |
|
C
|
China Reinsurance Group Corp
HKEX:1508
|
CN |
|
ALK-Abello A/S
CSE:ALK B
|
DK |
|
A
|
Arsenal Digital Holdings Inc
OTC:ADHI
|
CA |
|
W
|
Western Securities Co Ltd
SZSE:002673
|
CN |
|
C
|
Capinfo Company Ltd
HKEX:1075
|
CN |
|
Excellence Commercial Property & Facilities Management Group Ltd
HKEX:6989
|
CN |
During the last 3 months Theravance Biopharma Inc insiders have not bought any shares, and sold 108.1k USD worth of shares. The stock price has dropped by 16% over this period (open performance analysis).
The last transaction was made on
Mar 16, 2026
by
Farnum Rhonda
, who
sold
108.1k USD
worth of 
TBPH shares.
During the last 3 months Theravance Biopharma Inc insiders have not bought any shares, and sold 108.1k USD worth of shares. The stock price has dropped by 16% over this period (open performance analysis).
The last transaction was made on
Mar 16, 2026
by
Farnum Rhonda
, who
sold
108.1k USD
worth of TBPH shares.
Theravance Biopharma Inc
Glance View
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. The company is headquartered in George Town, Grand Cayman and currently employs 158 full-time employees. The company went IPO on 2014-05-16. The firm develops transformational medicines to improve the lives of patients suffering from serious illnesses. The firm's research is focused in the areas of inflammation and immunology. The company applies organ-selective knowledge to biologically compelling targets to discover and develop medicines, which are designed to treat underserved localized diseases and to limit systemic exposure. The firm is developing lung-selective medicines to treat respiratory disease, including YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its revefenacin is a long-acting muscarinic antagonist (LAMA). Its programs also include Nezulcitinib, Ampreloxetine (TD-9855), Izencitinib, TD-5202 and TD-8236.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
